Market Research

Continuous Renal Replacement Therapy Market Forecasts to 2028 – Global Analysis By Product Type (Disposables, Dialysates and Replacement Fluids, CRRT Systems and Other Product Type), Speed (Slow Continuous Ultrafiltration (SCUF), Continuous Venovenous Hem

Best Price Guarantee Length Publisher Published Date SKU
from $4,150 175 Pages Stratistics Market Research Consulting December, 2022 SMR17627138
Best Price Guarantee
Price from $4,150
Length 175 Pages
Publisher Stratistics Market Research Consulting
Published Date December, 2022
SKU SMR17627138

Continuous Renal Replacement Therapy Market Forecasts to 2028 – Global Analysis By Product Type (Disposables, Dialysates and Replacement Fluids, CRRT Systems and Other Product Type), Speed (Slow Continuous Ultrafiltration (SCUF), Continuous Venovenous Hemodialysis (CVVHD), Continuous Venovenous Hemodiafiltration (CVVHDF), Continuous Venovenous Hemofiltration (CVVH) and Other Modalities), Age Group, End User, and By Geography

According to Stratistics MRC, the Global Continuous Renal Replacement Therapy Market is accounted for $1.3 billion in 2022 and is expected to reach $2.4 billion by 2028 growing at a CAGR of 10.7% during the forecast period. Continuous renal replacement treatment is a sort of extracorporeal blood purification treatment for patients with kidney failure that is used constantly and gradually. It tends to mirror the kidneys procedures in electrolytes, toxic products, and water regulation to permanently remove fluid and solutes. Patients who are candidates for hemodialysis but cannot tolerate traditional intermittent hemodialysis are given this treatment.

According to the International Society of Nephrology, every year approximately 13.3 million cases of acute kidney injury globally, particularly high in emerging countries, where annual incidence is estimated to be 11.3 million. According to Centers for Disease Control and Prevention (CDC), approximately 30 million people are estimated to have chronic kidney disease (CKD).

Market Dynamics:

Driver:

Increasing occurrence of persistent kidney disease

The major factors contributing the growth of continuous renal replacement therapy market is raising incidence of chronic kidney disease, which is a major hazard factor for diabetes, hypertension, cardiovascular disease, and inflammatory disease of the kidney. The rise in the number of acute kidney injury cases and other technological advancements in the field of paediatric for the treatment of acute kidney injury in small infants are the factors expected to drive the growth of the market.

Restraint:

High procedural cost

As the population in emerging nations is price-sensitive, they prefer lower-priced products. Although the cost in developing countries is elevated which makes these measures are unaffordable for a large portion of the population due to the low acquiring power. This limits the demand and uptake of this therapy in the developed and developing countries. However, reimbursement, procedural costs, and high complexity and lack of trained nurses are the factors that are restraining the growth of market.

Opportunity:

Technological advancements

The use of the therapy in critically ill patients has significantly benefited from technological advances in equipment design. Such advancements have momentously expanded the field of extracorporeal therapies in the ICU. Moreover, software integration is likely to become a new tool for advanced equipment. Therefore, the implementation of advanced software solutions is expected to drive the growth of the market.

Threat:

Reformed Healthcare Regulations

Companies are subject to a number of existing laws & regulations and non-compliance, which is likely to adversely affect their business, financial condition and results of operations and companies are susceptible to a changing regulatory environment. As participants in the healthcare industry, the operations & products of companies are regulated by numerous government agencies is the factor hindering the market growth.

Covid-19 Impact

The transmission of this virus has a significant impact on many parts of the globe. In collaboration with governments throughout the world, pharmaceutical and biotech businesses are working to combat the pandemic, from vaccine development to logistics planning. Furthermore, routinely used medications have shown a significant increase in demand for treatment. Because many affluent countries are experiencing a shortage of these medications, the increasing demand has provided enormous prospects for management drug manufacturers. As a result, the continuous renal replacement therapy market is projected to be significantly impacted.

The continuous venovenous hemodiafiltration (CVVHDF) egment is expected to be the largest during the forecast period

The continuous venovenous hemodiafiltration (CVVHDF) segment is estimated to have a lucrative growth, due to the increase in dialysis procedures. This treatment modality results in comprehensive removal and replacement of solutes and fluids within the blood. It also includes principles of diffusion and convection, hence propelling the growth of the market.

The adults segment is expected to have the highest CAGR during the forecast period

The adults segment is anticipated to witness the fastest CAGR growth during the forecast period, due to various regulatory approvals for adult and rise in development of novel products. Additionally, adoption of various growth strategies by various market players are creating lucrative opportunities in the segment.

Region with highest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to rising technological advancement, surging healthcare expenditure. This is primarily attributed to increase in number of initiatives along with enhanced investments for the overall R&D of products. Additionally, surge in focus of leading manufacturers on expanding their geographical presence is the factor driving the region growth.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to rise in geriatric population and increasing incidences of acute kidney injury. High adoption rates of new technologies in continuous renal replacement therapy and the presence of well-established healthcare infrastructure is fueling the growth of the overall regional market to a large extent.

Key players in the market

Some of the key players profiled in the Continuous Renal Replacement Therapy Market include Nipro Corporation, Baxter International, Asahi Kasei Corporation, B. Braun Melsungen AG, Fresenius Medical Care, NxStage Medical, Inc., Toray Industries Inc., Medtronic plc, Anjue Medical Equipment Co. Ltd., Cytosorbents, Medites Pharma, spol. s.r.o, Ningbo Tianyi Medical Devices, SWS Hemodialysis Care, Medica S.p.A, Medical Components Inc., NIKKISO Co. Ltd., Infomed SA, Chongqing Shanwaishan Science and Technology and Bellco Societa Unipersonale a r.l.

Key Developments:

In April 2020, Fresenius Medical Care received US FDA Emergency Use Authorization for multiFiltrate PRO System and multiBic/multiPlus Solutions to provide CRRT to treat patients in an acute care environment during the COVID-19 pandemic.

In December 2020, Medtronic Plc announced the launch of a new Carpedium system. This system was the first neonatal and pediatric acute dialysis system created for treating patients who need renal replacement therapy.

In September 2017, B. Braun Launched xevonta, a next generation dialyzer for the U.S. market. Its advanced membrane technology helps in removing more toxins from a patient's blood. The new product launch will help in broadening its product portfolio.

Products Covered:
• Tubs, Cups, Boxes, and Pots
• Caps & Closures
• Rigid Bulk Products
• Cans
• Intermediate Bulk Containers (IBCs)
• Trays and Containers
• Bottles and Jars
• Others Products

Production Processes Covered:
• Extrusion
• Blow Molding
• Co-Extrusion
• Thermoforming (Thermo Fill Seal)
• Injection Molding
• Other Production Processes

Raw Materials Covered:
• Natural/Bio-Based Polymers (Bioplastics)
• Synthetic Polymers
• Other Raw Materials

End Users Covered:
• Building & Construction
• Industrial Packaging & Transport
• Healthcare/Medical
• Automotive
• Electrical & Electronics
• Pharmaceuticals
• Cosmetics & Personal Care
• Toiletries
• Beverage
• Food
• Other End Users

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Continuous Renal Replacement Therapy Market, By Product Type
5.1 Introduction
5.2 Disposables
5.3 Dialysates and Replacement Fluids
5.4 CRRT Systems
5.5 Other Product Type
6 Global Continuous Renal Replacement Therapy Market, By Modality
6.1 Introduction
6.2 Slow Continuous Ultrafiltration (SCUF)
6.3 Continuous Venovenous Hemodialysis (CVVHD)
6.4 Continuous Venovenous Hemodiafiltration (CVVHDF)
6.5 Continuous Venovenous Hemofiltration (CVVH)
6.6 Other Modalities
7 Global Continuous Renal Replacement Therapy Market, By Age Group
7.1 Introduction
7.2 Pediatrics
7.3 Adults
7.4 Other Age Groups
8 Global Continuous Renal Replacement Therapy Market, By End User
8.1 Introduction
8.2 Ambulatory Centers
8.3 Specially Clinics
8.4 Hospitals
8.5 Other End Users
9 Global Continuous Renal Replacement Therapy Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Nipro Corporation
11.2 Baxter International
11.3 Asahi Kasei Corporation
11.4 B. Braun Melsungen AG
11.5 Fresenius Medical Care
11.6 NxStage Medical, Inc.
11.7 Toray Industries Inc.
11.8 Medtronic plc
11.9 Anjue Medical Equipment Co. Ltd.
11.10 Cytosorbents
11.11 Medites Pharma spol. s.r.o
11.12 Ningbo Tianyi Medical Devices
11.11 SWS Hemodialysis Care
11.14 Medica S.p.A
11.15 Medical Components Inc.
11.16 NIKKISO Co. Ltd.
11.17 Infomed SA
11.18 Chongqing Shanwaishan Science and Technology
11.19 Bellco Societa Unipersonale a r.l
List of Tables
Table 1 Global Continuous Renal Replacement Therapy Market Outlook, By Region (2020-2028) ($MN)
Table 2 Global Continuous Renal Replacement Therapy Market Outlook, By Product Type (2020-2028) ($MN)
Table 3 Global Continuous Renal Replacement Therapy Market Outlook, By Disposables (2020-2028) ($MN)
Table 4 Global Continuous Renal Replacement Therapy Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
Table 5 Global Continuous Renal Replacement Therapy Market Outlook, By CRRT Systems (2020-2028) ($MN)
Table 6 Global Continuous Renal Replacement Therapy Market Outlook, By Other Product Type (2020-2028) ($MN)
Table 7 Global Continuous Renal Replacement Therapy Market Outlook, By Modality (2020-2028) ($MN)
Table 8 Global Continuous Renal Replacement Therapy Market Outlook, By Slow Continuous Ultrafiltration (SCUF) (2020-2028) ($MN)
Table 9 Global Continuous Renal Replacement Therapy Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
Table 10 Global Continuous Renal Replacement Therapy Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
Table 11 Global Continuous Renal Replacement Therapy Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
Table 12 Global Continuous Renal Replacement Therapy Market Outlook, By Other Modalities (2020-2028) ($MN)
Table 13 Global Continuous Renal Replacement Therapy Market Outlook, By Age Group (2020-2028) ($MN)
Table 14 Global Continuous Renal Replacement Therapy Market Outlook, By Pediatrics (2020-2028) ($MN)
Table 15 Global Continuous Renal Replacement Therapy Market Outlook, By Adults (2020-2028) ($MN)
Table 16 Global Continuous Renal Replacement Therapy Market Outlook, By Other Age Groups (2020-2028) ($MN)
Table 17 Global Continuous Renal Replacement Therapy Market Outlook, By End User (2020-2028) ($MN)
Table 18 Global Continuous Renal Replacement Therapy Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
Table 19 Global Continuous Renal Replacement Therapy Market Outlook, By Specially Clinics (2020-2028) ($MN)
Table 20 Global Continuous Renal Replacement Therapy Market Outlook, By Hospitals (2020-2028) ($MN)
Table 21 Global Continuous Renal Replacement Therapy Market Outlook, By Other End Users (2020-2028) ($MN)
Table 22 North America Continuous Renal Replacement Therapy Market Outlook, By Country (2020-2028) ($MN)
Table 23 North America Continuous Renal Replacement Therapy Market Outlook, By Product Type (2020-2028) ($MN)
Table 24 North America Continuous Renal Replacement Therapy Market Outlook, By Disposables (2020-2028) ($MN)
Table 25 North America Continuous Renal Replacement Therapy Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
Table 26 North America Continuous Renal Replacement Therapy Market Outlook, By CRRT Systems (2020-2028) ($MN)
Table 27 North America Continuous Renal Replacement Therapy Market Outlook, By Other Product Type (2020-2028) ($MN)
Table 28 North America Continuous Renal Replacement Therapy Market Outlook, By Modality (2020-2028) ($MN)
Table 29 North America Continuous Renal Replacement Therapy Market Outlook, By Slow Continuous Ultrafiltration (SCUF) (2020-2028) ($MN)
Table 30 North America Continuous Renal Replacement Therapy Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
Table 31 North America Continuous Renal Replacement Therapy Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
Table 32 North America Continuous Renal Replacement Therapy Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
Table 33 North America Continuous Renal Replacement Therapy Market Outlook, By Other Modalities (2020-2028) ($MN)
Table 34 North America Continuous Renal Replacement Therapy Market Outlook, By Age Group (2020-2028) ($MN)
Table 35 North America Continuous Renal Replacement Therapy Market Outlook, By Pediatrics (2020-2028) ($MN)
Table 36 North America Continuous Renal Replacement Therapy Market Outlook, By Adults (2020-2028) ($MN)
Table 37 North America Continuous Renal Replacement Therapy Market Outlook, By Other Age Groups (2020-2028) ($MN)
Table 38 North America Continuous Renal Replacement Therapy Market Outlook, By End User (2020-2028) ($MN)
Table 39 North America Continuous Renal Replacement Therapy Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
Table 40 North America Continuous Renal Replacement Therapy Market Outlook, By Specially Clinics (2020-2028) ($MN)
Table 41 North America Continuous Renal Replacement Therapy Market Outlook, By Hospitals (2020-2028) ($MN)
Table 42 North America Continuous Renal Replacement Therapy Market Outlook, By Other End Users (2020-2028) ($MN)
Table 43 Europe Continuous Renal Replacement Therapy Market Outlook, By Country (2020-2028) ($MN)
Table 44 Europe Continuous Renal Replacement Therapy Market Outlook, By Product Type (2020-2028) ($MN)
Table 45 Europe Continuous Renal Replacement Therapy Market Outlook, By Disposables (2020-2028) ($MN)
Table 46 Europe Continuous Renal Replacement Therapy Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
Table 47 Europe Continuous Renal Replacement Therapy Market Outlook, By CRRT Systems (2020-2028) ($MN)
Table 48 Europe Continuous Renal Replacement Therapy Market Outlook, By Other Product Type (2020-2028) ($MN)
Table 49 Europe Continuous Renal Replacement Therapy Market Outlook, By Modality (2020-2028) ($MN)
Table 50 Europe Continuous Renal Replacement Therapy Market Outlook, By Slow Continuous Ultrafiltration (SCUF) (2020-2028) ($MN)
Table 51 Europe Continuous Renal Replacement Therapy Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
Table 52 Europe Continuous Renal Replacement Therapy Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
Table 53 Europe Continuous Renal Replacement Therapy Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
Table 54 Europe Continuous Renal Replacement Therapy Market Outlook, By Other Modalities (2020-2028) ($MN)
Table 55 Europe Continuous Renal Replacement Therapy Market Outlook, By Age Group (2020-2028) ($MN)
Table 56 Europe Continuous Renal Replacement Therapy Market Outlook, By Pediatrics (2020-2028) ($MN)
Table 57 Europe Continuous Renal Replacement Therapy Market Outlook, By Adults (2020-2028) ($MN)
Table 58 Europe Continuous Renal Replacement Therapy Market Outlook, By Other Age Groups (2020-2028) ($MN)
Table 59 Europe Continuous Renal Replacement Therapy Market Outlook, By End User (2020-2028) ($MN)
Table 60 Europe Continuous Renal Replacement Therapy Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
Table 61 Europe Continuous Renal Replacement Therapy Market Outlook, By Specially Clinics (2020-2028) ($MN)
Table 62 Europe Continuous Renal Replacement Therapy Market Outlook, By Hospitals (2020-2028) ($MN)
Table 63 Europe Continuous Renal Replacement Therapy Market Outlook, By Other End Users (2020-2028) ($MN)
Table 64 Asia Pacific Continuous Renal Replacement Therapy Market Outlook, By Country (2020-2028) ($MN)
Table 65 Asia Pacific Continuous Renal Replacement Therapy Market Outlook, By Product Type (2020-2028) ($MN)
Table 66 Asia Pacific Continuous Renal Replacement Therapy Market Outlook, By Disposables (2020-2028) ($MN)
Table 67 Asia Pacific Continuous Renal Replacement Therapy Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
Table 68 Asia Pacific Continuous Renal Replacement Therapy Market Outlook, By CRRT Systems (2020-2028) ($MN)
Table 69 Asia Pacific Continuous Renal Replacement Therapy Market Outlook, By Other Product Type (2020-2028) ($MN)
Table 70 Asia Pacific Continuous Renal Replacement Therapy Market Outlook, By Modality (2020-2028) ($MN)
Table 71 Asia Pacific Continuous Renal Replacement Therapy Market Outlook, By Slow Continuous Ultrafiltration (SCUF) (2020-2028) ($MN)
Table 72 Asia Pacific Continuous Renal Replacement Therapy Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
Table 73 Asia Pacific Continuous Renal Replacement Therapy Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
Table 74 Asia Pacific Continuous Renal Replacement Therapy Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
Table 75 Asia Pacific Continuous Renal Replacement Therapy Market Outlook, By Other Modalities (2020-2028) ($MN)
Table 76 Asia Pacific Continuous Renal Replacement Therapy Market Outlook, By Age Group (2020-2028) ($MN)
Table 77 Asia Pacific Continuous Renal Replacement Therapy Market Outlook, By Pediatrics (2020-2028) ($MN)
Table 78 Asia Pacific Continuous Renal Replacement Therapy Market Outlook, By Adults (2020-2028) ($MN)
Table 79 Asia Pacific Continuous Renal Replacement Therapy Market Outlook, By Other Age Groups (2020-2028) ($MN)
Table 80 Asia Pacific Continuous Renal Replacement Therapy Market Outlook, By End User (2020-2028) ($MN)
Table 81 Asia Pacific Continuous Renal Replacement Therapy Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
Table 82 Asia Pacific Continuous Renal Replacement Therapy Market Outlook, By Specially Clinics (2020-2028) ($MN)
Table 83 Asia Pacific Continuous Renal Replacement Therapy Market Outlook, By Hospitals (2020-2028) ($MN)
Table 84 Asia Pacific Continuous Renal Replacement Therapy Market Outlook, By Other End Users (2020-2028) ($MN)
Table 85 South America Continuous Renal Replacement Therapy Market Outlook, By Country (2020-2028) ($MN)
Table 86 South America Continuous Renal Replacement Therapy Market Outlook, By Product Type (2020-2028) ($MN)
Table 87 South America Continuous Renal Replacement Therapy Market Outlook, By Disposables (2020-2028) ($MN)
Table 88 South America Continuous Renal Replacement Therapy Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
Table 89 South America Continuous Renal Replacement Therapy Market Outlook, By CRRT Systems (2020-2028) ($MN)
Table 90 South America Continuous Renal Replacement Therapy Market Outlook, By Other Product Type (2020-2028) ($MN)
Table 91 South America Continuous Renal Replacement Therapy Market Outlook, By Modality (2020-2028) ($MN)
Table 92 South America Continuous Renal Replacement Therapy Market Outlook, By Slow Continuous Ultrafiltration (SCUF) (2020-2028) ($MN)
Table 93 South America Continuous Renal Replacement Therapy Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
Table 94 South America Continuous Renal Replacement Therapy Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
Table 95 South America Continuous Renal Replacement Therapy Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
Table 96 South America Continuous Renal Replacement Therapy Market Outlook, By Other Modalities (2020-2028) ($MN)
Table 97 South America Continuous Renal Replacement Therapy Market Outlook, By Age Group (2020-2028) ($MN)
Table 98 South America Continuous Renal Replacement Therapy Market Outlook, By Pediatrics (2020-2028) ($MN)
Table 99 South America Continuous Renal Replacement Therapy Market Outlook, By Adults (2020-2028) ($MN)
Table 100 South America Continuous Renal Replacement Therapy Market Outlook, By Other Age Groups (2020-2028) ($MN)
Table 101 South America Continuous Renal Replacement Therapy Market Outlook, By End User (2020-2028) ($MN)
Table 102 South America Continuous Renal Replacement Therapy Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
Table 103 South America Continuous Renal Replacement Therapy Market Outlook, By Specially Clinics (2020-2028) ($MN)
Table 104 South America Continuous Renal Replacement Therapy Market Outlook, By Hospitals (2020-2028) ($MN)
Table 105 South America Continuous Renal Replacement Therapy Market Outlook, By Other End Users (2020-2028) ($MN)
Table 106 Middle East & Africa Continuous Renal Replacement Therapy Market Outlook, By Country (2020-2028) ($MN)
Table 107 Middle East & Africa Continuous Renal Replacement Therapy Market Outlook, By Product Type (2020-2028) ($MN)
Table 108 Middle East & Africa Continuous Renal Replacement Therapy Market Outlook, By Disposables (2020-2028) ($MN)
Table 109 Middle East & Africa Continuous Renal Replacement Therapy Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
Table 110 Middle East & Africa Continuous Renal Replacement Therapy Market Outlook, By CRRT Systems (2020-2028) ($MN)
Table 111 Middle East & Africa Continuous Renal Replacement Therapy Market Outlook, By Other Product Type (2020-2028) ($MN)
Table 112 Middle East & Africa Continuous Renal Replacement Therapy Market Outlook, By Modality (2020-2028) ($MN)
Table 113 Middle East & Africa Continuous Renal Replacement Therapy Market Outlook, By Slow Continuous Ultrafiltration (SCUF) (2020-2028) ($MN)
Table 114 Middle East & Africa Continuous Renal Replacement Therapy Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
Table 115 Middle East & Africa Continuous Renal Replacement Therapy Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
Table 116 Middle East & Africa Continuous Renal Replacement Therapy Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
Table 117 Middle East & Africa Continuous Renal Replacement Therapy Market Outlook, By Other Modalities (2020-2028) ($MN)
Table 118 Middle East & Africa Continuous Renal Replacement Therapy Market Outlook, By Age Group (2020-2028) ($MN)
Table 119 Middle East & Africa Continuous Renal Replacement Therapy Market Outlook, By Pediatrics (2020-2028) ($MN)
Table 120 Middle East & Africa Continuous Renal Replacement Therapy Market Outlook, By Adults (2020-2028) ($MN)
Table 121 Middle East & Africa Continuous Renal Replacement Therapy Market Outlook, By Other Age Groups (2020-2028) ($MN)
Table 122 Middle East & Africa Continuous Renal Replacement Therapy Market Outlook, By End User (2020-2028) ($MN)
Table 123 Middle East & Africa Continuous Renal Replacement Therapy Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
Table 124 Middle East & Africa Continuous Renal Replacement Therapy Market Outlook, By Specially Clinics (2020-2028) ($MN)
Table 125 Middle East & Africa Continuous Renal Replacement Therapy Market Outlook, By Hospitals (2020-2028) ($MN)
Table 126 Middle East & Africa Continuous Renal Replacement Therapy Market Outlook, By Other End Users (2020-2028) ($MN)

$4,150
$7,500

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings